Cargando...
Sodium‐glucose co‐transporter 2 inhibitors for type 2 diabetes mellitus: An overview for the primary care physician
AIMS: Sodium‐glucose co‐transporter type 2 (SGLT2) inhibitors are a new class of anti‐hyperglycaemic agents in type 2 diabetes mellitus (T2DM). This review examines their mechanism of action and provides an overview of safety and efficacy from the main studies of SGLT2 inhibitors marketed in the Uni...
Gardado en:
| Publicado en: | Int J Clin Pract |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5518299/ https://ncbi.nlm.nih.gov/pubmed/28440009 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijcp.12937 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|